Sensei Biotherapeutics Inc (SNSE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $30.22
• Market Cap: $43.19M
• EPS: $-19.14
• 52-Week High: $36.76
• 52-Week Low: $5.00

Market Sentiment

Sensei Biotherapeutics Inc currently has a Bullish sentiment score of 0.29.

About Sensei Biotherapeutics Inc

Sensei Biotherapeutics, Inc. is a clinical-stage immunotherapy company based in Rockville, Maryland, committed to pioneering innovative therapies designed to combat cancer. By harnessing advanced scientific approaches, Sensei aims to develop novel treatments that engage the immune system to fight tumors effectively. With a robust pipeline and a focus on the intersection of biotechnology and patient care, the company is positioned to make significant contributions to the evolving landscape of ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Sensei Biotherapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SNSE pay dividends?

Sensei Biotherapeutics Inc (SNSE) does not currently pay a regular dividend.

What is SNSE's market cap?

Sensei Biotherapeutics Inc (SNSE) has a market capitalization of $43.19M with a current stock price of $30.22.